NCT02080078 2019-05-03A Phase I Dose Escalation Study of Erlotinib in Combination With TheophyllineAHS Cancer Control AlbertaPhase 1 Terminated15 enrolled
NCT01799161 2014-11-17Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung CancerUniversity of MiamiPhase 1 Withdrawn